Main Article Content
An aerosol can have variations in formulation as per the area of application and intention of use. In short aerosol formulations are the best NDDS for dispensing Active Pharmaceutical Ingredients (APIâ€™s) to the systemic circulation as well as faster local action as compared to OSD. As this dosage form is applied topically, it does not affect the major organs of the body. It has been concluded that it does not show or shows minimum hypersensitivity to locally applied area. It shows best bioavailability as compared to the OSD & desired pharmacological effect. Now a days, new excipients are being used to used get the better formulation efficacy and for batter patientâ€™s compliance. According to the formulation to be processed, we should use specific excipients as conformed by the assay procedure in respective furmularary or pharmacopoeia. From various excipients like colorants, disintigrants, antiadherants, lubricants, sweeteners, binders, flavourin agents, glidants, sorbents, preservatives and vehicles,Â Â various dosage forms were formulated as per target and bioavailability. The present review is based on the excipients used in topical pharmaceutical aerosols and its variations.
Glass B.D., Australanprescriber.com/magazine, Haywood. 2011,A ,vol. 34(4);
Fentakis M.E., Choulis N.H, Science direct IJP; Papadimitriou E., 1992, vol. 86 (2);
Aulton,; M.E. ; Cooper J.W. Pharmaceutics : the science of dosage form design. 2003, 2, 734
Ursino, M.G., et al., Excipients in medicinal products used in gastroenterology as a possible cause of side effects. Regul Toxicol Pharmacol, 2011.
M. DouVsa, P., et al., Drug-excipient compatibility testing - identification and characterization of degradation products of phenylephrine in several pharmaceutical formulations against the common cold,. Drug-excipient compatibility testing - identification and characterization of degradation products of phenylephrine in several pharmaceutical formulations against the common cold,, 2011. In Press.
Fabiano, V., C. Mameli, and G. V. Zuccotti, Paediatric pharmacology: Remember the excipients. Pharmacol Res, 2011. In Press.
Composition and Aerosol Spray Dispenser for Eliminating Odors in Air US patent, 20,070,194,040 A1, 2007
M. E. Aulton, K. Taylor, Aulton's Pharmaceutics: The Design and Manufacture of Medicines
J. Green, E. Gommeren, K. Palmer, pharmaceutical aerosols â€“ enhancing the metered dose inhaler, Du pont-the miracle of science,2011
Committee of experts on the transport of dangerous goods and on the globally harmonized system of classification and labelling of chemicals. From web www.google.com.
F. Chen, Toxicology and Cellular Effect of Manufactured Nanomaterials US patent 20,120,315,218 A9, 2012
D. D. Roberts, P. D. R. Soto, Methods for modulating chemotherapeutic cytotoxicity WO 2,014,160,183 A1, 2014
Physiological Aspects of Compatibility and Incompatibility in Grafted Cucumber Seedlings, Journal of the American Society for Horticultural Science, 2011
Ultraviolet and visible spectroscopy, 2008, 2nd ed.
I. P. b. Sousa, A. B. SchnÃ¼rch, Presystemic metabolism of orally administered drugs and strategies to overcome it, sciencedirect, Journal of Controlled Release Volume 192, 28 October 2014, Pages 301â€“309
Pharmaceutical inhalation aerosol technology, 2015,2nd ed.
S. Mills., FIP, Pharmaceutical excipients-an overview including considerations for paediatric dosing, WHO presentation Beijing; 2010.
Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach, World Health Organization, Geneva, 2007. And Asthma Foundation. www.asthmafoundation.org.au/rhinitis.aspx. Accessed 3 May, 2013.
Design of Composite Particles via Spray Drying for DPI Formulations ON drug Delivery, Hovione, 2014.
AARC; Coding Guidelines for Certain Respiratory Care Services â€“ January 2016
UNC eshelman school of pharmacy, the pharmaceutics and compounding laboratory; http://pharmlabs.unc.edu/labs/aerosols/formulation.htm
Pub chem. References web: